Biotechnology CRO · Contract Research Services
Biotechnology CRO and Contract Research Services in India
Manna Biotech partners with pharma, nutraceutical, biotech and startup teams on research-stage programs: feasibility, assay development, molecular characterisation, microbiology, testing and NGS-based analytics. Indian and eligible international projects are delivered through written scope, milestones, documented methods and full data transparency.
Inside Manna Biotech
Stock photos shown for visual context · real lab work in our student gallery.
CRO & CRS capabilities
Focused biotechnology research capability for defined commercial questions.
Discovery & early research
Target identification, proof-of-concept assays, literature due diligence, and feasibility studies.
Assay, method & biomarker development
Research-use PCR/qPCR assays, method optimisation and feasible biomarker discovery or validation plans with defined controls and endpoints.
Genomics & sequencing
Sequencing and existing-data analysis requirements, with platform, execution route, QC and deliverables confirmed for the specific project.
Microbial & probiotic characterisation
16S / whole-genome profiling of probiotic strains, contamination profiling, and community analysis.
Nutraceutical & plant science
Plant DNA barcoding, adulteration detection, and molecular authentication for the herbal and nutraceutical sector.
In-vitro & molecular validation
Feasible current cell-culture, microbiology and molecular endpoints connected to sequencing, bioinformatics and statistical interpretation.
Custom study design
End-to-end protocol design with defined endpoints, timelines and deliverables agreed before kick-off. In-vivo, toxicology and regulated work require separately verified facilities and responsibilities.
Plan your project
Write a contract-research scope that can be checked
A contract-research brief should connect the scientific objective to work packages, responsibilities and evidence. This is particularly useful when a pharma, biotech or academic project combines experiments and analysis. Listing techniques alone does not say what completion means or who can authorise a change.
Decision 1
Define the boundary of each work package
For every proposed module, specify the question, input material or data, method to be reviewed and expected output. Distinguish client-provided inputs from work being requested. If one stage depends on another passing a quality check, show that dependency so the quote does not imply automatic progression.
Decision 2
Make repeats and changes explicit
Discuss how technical repeats, unsuitable samples and changes to the original question will be handled. A failed quality check and an unfavourable biological result are different events. Agree which review triggers a repeat, a revised scope or a stop, and who approves additional work and cost.
Decision 3
Name the execution and review responsibilities
Confirm who performs each method and who reviews the output. Any external facility, specialist assay or regulated report needs its own verification; a CRO engagement does not establish those capabilities by itself. For pharma research, identify whether the requested evidence is exploratory or intended for a separately qualified regulatory pathway.
Specify what remains useful after the engagement
Ask for the agreed primary data, methods or workflow versions, sample-to-result traceability, exclusions and limitations alongside the report. Document the retention and handover arrangements in the scope. A polished summary alone may be insufficient for your team to review, reproduce or extend the work.
India-Based, Internationally Accessible
A specialist research-stage CRO with clear boundaries and accountable delivery.
Manna Biotech is positioned for focused life-science work where direct scientist access, flexible scope and documented outputs matter. We do not present research-stage services as clinical-trial, GLP or statutory testing when they are not.
Remote scope and data work
International clients can scope projects, review protocols, exchange authorised data and receive bioinformatics or documented research outputs remotely.
Physical sample feasibility
Indian samples are handled under agreed submission instructions. International sample movement is accepted only after matrix, biosafety, courier, customs and import feasibility are confirmed.
Compliance routed correctly
Research-stage work stays within confirmed Manna capability. GLP, GMP, NABL, ISO 17025 or statutory requirements are identified during scoping and require a separately verified qualified facility before acceptance.
Related services
Connect a contract-research project to the right scientific capability.
Preclinical feasibility
Discuss a proposed in-vivo study only after external facility, ethics and execution responsibilities are verified.
Agri-biotech research and testing
Scope plant, agricultural-microbiology and molecular research-use questions.
R&D & product development
Start with a broader research, assay-development or product-development scope led by Manna Biotech scientists.
Molecular testing & diagnostics
Request a defined molecular, microbiology or sequencing testing service with scientist-interpreted results.
In-vitro research services
Scope feasible cell-culture, microbiology and molecular endpoints with explicit model, control and capability review.
Bioinformatics & NGS analysis
Connect sequencing or client-provided data to reproducible analysis, figures and scientist interpretation.
Patent data & technical support
Explore prior-art, patent landscape and experimental data support for life-science innovation.
Engagement models
From a feasibility study to a multi-phase contract research programme.
CRO engagements are scoped under project-specific proposals. NDA available on request before any detailed discussion. Data access, ownership and IP terms require written agreement.
Discovery engagement
Short scoped studies — proof of concept, feasibility, or due diligence.
Method development
Assay or pipeline development with validation and transfer documentation.
Multi-phase program
Long-running CRO partnerships under a master services agreement (MSA).
Research or testing retainer
Recurring analysis, testing or R&D support with an agreed scope, cadence, reporting format and named scientific contact.
Fee Structure
CRO engagements — scoped, budgeted, and delivered under NDA.
Every CRO project is different — a 6-week feasibility study costs nothing like an 18-month multi-phase program. We work with you to define scope, milestones, deliverables, and budget in a scoping document before any commitment. Request and agree confidentiality terms before sharing detailed IP.
- Confidentiality terms agreed before detailed IP is shared
- Written scope & budget document before project kickoff
- Payment and acceptance terms stated in the approved proposal
Data access, ownership and IP terms require written agreement. Methods documentation, deliverables, invoicing currency and payment conditions must be confirmed in the approved proposal.
FAQ
Common questions.
Who are your typical CRO clients?+
Pharma R&D teams, nutraceutical brands, biotech startups, diagnostic companies, and academic groups looking to outsource specific research modules.
What do CRO and Contract Research Services (CRS) mean at Manna Biotech?+
They describe research modules performed under contract for a client, such as feasibility, assay development, molecular testing, microbial characterisation, sequencing or bioinformatics. Manna Biotech focuses on research-stage biotechnology work rather than presenting itself as a full-service clinical-trial CRO.
Do you sign NDAs?+
Yes — we routinely sign mutual NDAs before any detailed scope discussion. Request one via admin@mannabiotech.com.
What's your data ownership policy?+
Agree data access, deliverable ownership, permitted use and IP rights in writing, including any pre-existing, contributor and institutional rights, before a project is confirmed.
Can you handle regulated studies?+
We focus on research-stage work. GLP, GMP, accredited or statutory scopes are not accepted as current Manna capability unless the required qualified facility, approval scope and reporting responsibility are verified for that project.
Do you provide in-vivo or preclinical studies?+
Manna Biotech does not present an owned animal facility or a blanket in-vivo service. A preclinical requirement is considered only after a suitable facility, approvals, execution responsibility, study scope and reporting route are separately verified in writing.
Can international companies engage Manna Biotech?+
Yes, for eligible research-stage scopes. Remote design, bioinformatics, data review and reporting can be delivered internationally. Physical samples are accepted only after shipping, biosafety, customs and import feasibility are confirmed for the specific material and country.
What belongs in a first CRO scope-of-work brief?+
Identify the research objective and work package, the client-provided samples or data, proposed controls and comparisons, expected data or documentation deliverables, preferred milestones, and the feasibility or permission questions that need resolution. Separate work you expect Manna Biotech to assess from activities retained by your own team or another facility. Note any reporting or quality requirements early. Begin with a non-confidential summary; detailed intellectual property should follow an agreed information-sharing process. Scope, responsibilities and acceptance criteria need review before a project is confirmed.
Get started
Have a CRO or Contract Research Services requirement?
Share the non-confidential outline first: company, scientific objective, sample or assay type, expected deliverables, compliance needs, country and timeline. We will confirm fit and arrange an NDA before detailed IP is discussed.